Handelsbanken Fonder’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.31M Sell
34,476
-885
-3% -$174K 0.02% 423
2026
Q1
$6.93M Sell
35,361
-91
-0.3% -$17.7K 0.02% 427
2025
Q4
$6.15M Sell
35,452
-1,957
-5% -$356K 0.02% 453
2025
Q3
$7.13M Buy
37,409
+2,811
+8% +$499K 0.02% 424
2025
Q2
$6.21M Buy
34,598
+6,550
+23% +$1.14M 0.02% 400
2025
Q1
$4.75M Sell
28,048
-440
-2% -$72.3K 0.02% 432
2024
Q4
$4.3M Buy
28,488
+542
+2% +$84.3K 0.02% 458
2024
Q3
$4.34M Sell
27,946
-923
-3% -$138K 0.02% 457
2024
Q2
$3.95M Sell
28,869
-11,606
-29% -$1.59M 0.02% 449
2024
Q1
$5.39M Sell
40,475
-40,644
-50% -$5.27M 0.02% 436
2023
Q4
$11.2M Sell
81,119
-28,408
-26% -$3.73M 0.05% 317
2023
Q3
$13.3M Buy
109,527
+6,221
+6% +$829K 0.07% 266
2023
Q2
$14.5M Buy
103,306
+19,062
+23% +$2.63M 0.08% 266
2023
Q1
$11.9M Buy
84,244
+24,429
+41% +$3.5M 0.07% 292
2022
Q4
$9.36M Buy
59,815
+3,892
+7% +$559K 0.06% 320
2022
Q3
$6.86M Buy
55,923
+9,445
+20% +$1.24M 0.05% 354
2022
Q2
$6.18M Buy
46,478
+35,226
+313% +$4.8M 0.04% 387
2022
Q1
$1.54M Sell
11,252
-12,075
-52% -$1.68M 0.01% 643
2021
Q4
$4.04M Sell
23,327
-2,843
-11% -$433K 0.02% 507
2021
Q3
$3.8M Sell
26,170
-1,301
-5% -$190K 0.02% 514
2021
Q2
$3.63M Sell
27,471
-5,442
-17% -$713K 0.02% 528
2021
Q1
$4.22M Sell
32,913
-3,128
-9% -$385K 0.02% 472
2020
Q4
$4.29M Sell
36,041
-549
-2% -$66.9K 0.03% 443
2020
Q3
$4.19M Buy
36,590
+1,883
+5% +$222K 0.03% 399
2020
Q2
$3.96M Buy
+34,707
New +$3.68M 0.03% 391
2016
Q1
Sell
-19,076
Closed -$1.36M 317
2015
Q4
$1.36M Buy
+19,076
New +$1.28M 0.03% 434

Other funds holding DGX

Handelsbanken Fonder's DGX Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Quest Diagnostics (DGX) stake by 2.5% in Q2 2026, selling an estimated $174K and leaving 34,476 shares worth $7.31M. The position accounts for 0.02% of the portfolio, ranked #423.

Handelsbanken Fonder first reported a position in DGX in Q4 2015 and has held it in 26 quarters since. The position peaked at $14.5M in Q2 2023. 736 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Handelsbanken Fonder held 34,476 shares of Quest Diagnostics worth $7.31M as of Q2 2026.
  • Handelsbanken Fonder sold 885 Quest Diagnostics shares in Q2 2026, an estimated $174K.
  • Quest Diagnostics made up 0.02% of Handelsbanken Fonder's portfolio in Q2 2026, its #423 holding.
  • Handelsbanken Fonder first reported a position in Quest Diagnostics in Q4 2015 and has held it in 26 quarters since.
  • Handelsbanken Fonder's Quest Diagnostics position peaked at $14.5M in Q2 2023.
  • 736 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.